PMN — ProMIS Neurosciences Balance Sheet
0.000.00%
- $39.67m
- $37.14m
Annual balance sheet for ProMIS Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | fx Final | fx Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.31 | 0.841 | 17 | 5.91 | 12.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.057 | 0.031 | — | — | 0.079 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.56 | 0.975 | 17.7 | 6.9 | 13.6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0.078 | 0.005 | 0 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 1.6 | 1.09 | 17.7 | 6.92 | 13.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.29 | 1.89 | 0.929 | 6.41 | 9.35 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.29 | 1.89 | 12.1 | 8.27 | 9.87 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.307 | -0.798 | 5.66 | -1.35 | 3.75 |
Total Liabilities & Shareholders' Equity | 1.6 | 1.09 | 17.7 | 6.92 | 13.6 |
Total Common Shares Outstanding |